English | Español
Patient Daily | Mar 25, 2026

LivaNova aura6000 Obstructive Sleep Apnea treatment granted FDA premarket approval
Patient Daily | Mar 25, 2026

FDA clears Spinal Elements Ventana A ALIF implant; first cases performed in Texas, US
Patient Daily | Mar 25, 2026

Researchers report hepatitis C drug may stop hepatitis E virus replication
Patient Daily | Mar 25, 2026

Oral semaglutide does not slow early Alzheimer’s decline in phase 3 trials, study finds
Patient Daily | Mar 25, 2026

GLP-1 drugs cut heart and kidney risks in type 1 diabetes study
Patient Daily | Mar 25, 2026

Experts discuss evolving guidelines for blood pressure control in older adults
Patient Daily | Mar 25, 2026

Losing health insurance worsens diabetes outcomes in low-income adults
Patient Daily | Mar 25, 2026

Study finds addiction risk tied to reward and impulse genes

Trending
+ Pharmaceuticals
Patient Daily | Mar 22, 2026

BioMarin pauses dosing and enrollment in two Voxzogo studies after safety signal
+ Pharmaceuticals
Patient Daily | Mar 25, 2026

Revolution and Ascendis identified as top buyout targets amid speculation of industry mega-merger
+ Pharmaceuticals
Patient Daily | Mar 22, 2026

FDA rejects REGENXBIO’s Hunter syndrome therapy as Denali awaits decision on rival drug
+ Pharmaceuticals
Patient Daily | Mar 25, 2026

Sarepta to seek full FDA approval for Duchenne therapies after failed confirmatory trial